Nutrien Stock Price, Forecast & Analysis (NYSE:NTR)

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Nutrien announced a quarterly dividend on Tuesday, July 30th. Shareholders of record on Monday, September 30th will be paid a dividend of $0.45 per share on Thursday, October 17th. This represents a $1.80 dividend on an annualized basis and a yield of 3.78%. The ex-dividend date of this dividend is Friday, September 27th. This is an increase from Nutrien's previous quarterly dividend of $0.43. View Nutrien's Dividend History.

Nutrien Ltd (NYSE:NTR) released its quarterly earnings results on Monday, November, 4th. The company reported $0.24 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.36 by $0.12. The company earned $4.13 billion during the quarter, compared to analyst estimates of $4.02 billion. Nutrien had a net margin of 20.95% and a return on equity of 6.49%. The business's quarterly revenue was up 3.6% compared to the same quarter last year. During the same period in the prior year, the business posted $0.47 earnings per share. View Nutrien's Earnings History.

Nutrien is scheduled to release their next quarterly earnings announcement on Wednesday, February 5th 2020. View Earnings Estimates for Nutrien.

15 brokers have issued twelve-month target prices for Nutrien's stock. Their forecasts range from $50.00 to $70.00. On average, they expect Nutrien's stock price to reach $61.00 in the next twelve months. This suggests a possible upside of 28.0% from the stock's current price. View Analyst Price Targets for Nutrien.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 4 hold ratings, 10 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Nutrien.

Press coverage about NTR stock has been trending positive on Wednesday, InfoTrie Sentiment reports. The research group identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Nutrien earned a media sentiment score of 2.3 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Nutrien.

Nutrien saw a decline in short interest in October. As of October 31st, there was short interest totalling 3,960,000 shares, a decline of 17.7% from the September 30th total of 4,810,000 shares. Based on an average daily trading volume, of 1,080,000 shares, the short-interest ratio is currently 3.7 days. Approximately 0.7% of the company's shares are sold short. View Nutrien's Current Options Chain.

Some companies that are related to Nutrien include CF Industries (CF), Mosaic (MOS), Israel Chemicals (ICL), Scotts Miracle-Gro (SMG), Nufarm (NUF), American Vanguard (AVD), CVR Partners (UAN), Marrone Bio Innovations (MBII), Calyxt (CLXT), Wynnstay Group (WYN), Evogene (EVGN), Arcadia Biosciences (RKDA), SenesTech (SNES), China Green Agriculture (CGA) and Eden Research (EDEN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Cimarex Energy (XEC), General Electric (GE), JPMorgan Chase & Co. (JPM), Micron Technology (MU), Verizon Communications (VZ), Cisco Systems (CSCO), CVS Health (CVS), Wells Fargo & Co (WFC) and Exxon Mobil (XOM).

Nutrien's stock is owned by many different of institutional and retail investors. Top institutional investors include Beutel Goodman & Co Ltd. (2.30%), CIBC Asset Management Inc (1.25%), Great West Life Assurance Co. Can (0.96%), Cambiar Investors LLC (0.48%), Sumitomo Mitsui Trust Holdings Inc. (0.43%) and Letko Brosseau & Associates Inc. (0.25%).

NTR stock was sold by a variety of institutional investors in the last quarter, including Cambiar Investors LLC, Beutel Goodman & Co Ltd., Addenda Capital Inc., CWM LLC, QV Investors Inc., Russell Investments Group Ltd., Tocqueville Asset Management L.P. and Sumitomo Mitsui Trust Holdings Inc..

NTR stock was bought by a variety of institutional investors in the last quarter, including TIAA FSB, Great West Life Assurance Co. Can, Alberta Investment Management Corp, Zurcher Kantonalbank Zurich Cantonalbank, Massachusetts Financial Services Co. MA, ARGA Investment Management LP, Tower Research Capital LLC TRC and BBVA USA Bancshares Inc..

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of NTR stock can currently be purchased for approximately $47.67.

Nutrien has a market capitalization of $27.31 billion and generates $19.64 billion in revenue each year. The company earns $3.57 billion in net income (profit) each year or $2.69 on an earnings per share basis. Nutrien employs 20,300 workers across the globe.View Additional Information About Nutrien.

The official website for Nutrien is http://www.nutrien.com/.

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]